Role of circular RNA in neurological disease

Role of circular RNA in neurological disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliographic Details
Main Author:	Salsabil, Labiba
Other Authors:	Chowdhury, Namara Mariam
Format:	Thesis
Language:	English
Published:	Brac University 2024
Subjects:	Circular RNA circRNA Neurological disorder Alzheimer’s disease Parkinson’s disease Nervous system > Diseases. Molecular neurobiology.
Online Access:	http://hdl.handle.net/10361/23932

Similar Items

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
by: Dey, Manashi
Published: (2024)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
by: Halim, Rabea
Published: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
by: Zaman, Rubaiyat
Published: (2024)

Targeting circular RNA for cardiovascular diseases
by: Sarkar, Deepannita
Published: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
by: Bakar, Osama Bin Abu
Published: (2024)

RNA drugs and RNA targets for small molecules: Prospects and challenges
by: Islam, Md. Raihanul
Published: (2024)

Implications of unusual non-coding RNAs in human diseases
by: Ahmed, Tazkia
Published: (2021)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
by: Mostofa, Golam
Published: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
by: Chowdhury, Sariya Uzrat
Published: (2022)

A review on optogenetics and its potential in neurological disorder management
by: Armin, Fariza
Published: (2024)

A computational approach to design putative potential siRNAs for silencing the nucleoprotein and surface glycoprotein gene of MARV
by: Suraiya, Tasnia Iffat
Published: (2023)

Gene editing for neurodegenerative diseases-A review
by: Sharna, Anika Islam
Published: (2023)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
by: Ferdous, Labiba
Published: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
by: Alim, Abdul
Published: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
by: Annee, Israt Jahan
Published: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
by: Tasneem, Sadia
Published: (2021)

A review paper on developing novel antiviral strategies against pathogenic RNA viruses
by: Nawar, Numia
Published: (2021)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
by: Tabassum, Nadira
Published: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
by: Afsana, Nourin
Published: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
by: Islam, Md. Irfath
Published: (2023)

Unlocking the therapeutic potential of RNA: a comprehensive review of RNA-based therapy
by: Ahmad, Rafid Uddin, et al.
Published: (2024)

Role of voltage-gated sodium channel modulators in peripheral nervous system disorders
by: Mithila, Sabekun Nahar
Published: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
by: Shehab, Habibul Mohsin
Published: (2024)

A review on RNAi technology and its therapeutic potential in Cancer
by: Mahaleka, Aarshi
Published: (2024)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
by: Aziz, Farhin
Published: (2019)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
by: Islam, Md. Rakibul
Published: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
by: Karmaker, Swastika
Published: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
by: Key, Nasrin Sultana
Published: (2023)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
by: Rawshan, A. E. Maisha
Published: (2022)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
by: Ishrat, Nowshin
Published: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
by: Saha, Bithi Rani
Published: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
by: Chowdhury, Amal
Published: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
by: Afreen, Nuraia
Published: (2021)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
by: Hassan, Md. Muhtaz
Published: (2020)

A review on the role of Myc and miRNA in Glioblastoma multiforme
by: Naureen, Ishrat
Published: (2022)

Review on: the mechanism and function of Glia in parkinson's disease
by: Abedin, Khondokar Mezbahul
Published: (2023)

Alzheimer's disease and marriage : an intimate account /
by: Wright, Lore K.
Published: (1993)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
by: Tamanna, Mst. Taskia
Published: (2023)

In silico analysis revealed hsa-miR-19a-3p and hsa-miR-19b-3p as two potential inhibitors of EGF mRNA in Breast Cancer
by: Nuha, Nabiha Tahsin
Published: (2024)

Detection of Parkinson’s disease from Neuro-imagery using deep neural network with transfer learning
by: Asaduzzaman, et al.
Published: (2021)